Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $496.01 million versus the consensus estimate of $458.98 million.

GUIDANCE:

Alkermes sees FY2026 revenue of $1.73-1.84 billion, versus the consensus of $1.81 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.